A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

National Institutes of Health (NIH)

Status and phase: Unknown; Phase 2

Conditions: Substance-Related Disorders

Treatments: Behavioral: Behavior Therapy

Study type: Interventional

Funder types: NIH

Identifiers

NCT00033124

NIDA-CTO-0009-1

Details and patient eligibility

About

The purpose of this study is to examine behavioral treatment for methamphetamine dependence.

Full description

To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence.

Exclusion criteria

Additional criteria available during screening at the site.